NEW YORK (GenomeWeb) – GenomeNext announced today that it has embedded Genomenon's Mastermind analytic and data visualization tool into its Olympus platform for genomic data analysis.
Launched about a year ago, Mastermind mines millions of medical publications to provide disease-gene-variant relationships curated from primary medical literature, organized into clinical categories, and prioritized by the strength of evidence. GenomeNext said it has now integrated Mastermind search results into Olympus in order to accelerate and automate variant curation required for clinical genomic interpretation.
GenomeNext said it has also signed a reseller agreement with Genomenon to sell the professional version of Mastermind to its Olympus users.
"We're excited to introduce Olympus as the first automated, end-to-end genomic analysis platform that includes a comprehensive genomic search engine for associated medical literature, dramatically reducing the time and costs of variant curation, annotation, and interpretation," GenomeNext CEO James Hirmas said in a statement.
In late 2017, LifeOmic signed a deal with Genomenon to use Mastermind in its genome sequencing data analysis platform.